Article
Enzyme replacement therapy for hypophosphatasia—The current paradigm
14 Jul 2024
Abstract excerpt
Hypophosphatasia (HPP) is a rare, inherited, and systemic disorder characterized by impaired skeletal mineralization and low tissue nonspecific serum alkaline phosphatase (TNSALP) activity. It is caused by either autosomal recessive or dominant-negative mutations in the gene that encodes TNSALP. The phenotype of HPP is very broad including abnormal bone mineralization, disturbances of calcium and phosphate...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
